Company intelligence / Profile preview

DeNova

Halifax, Nova Scotia, Canada

Ownership: Private
Development stage: Commercial

Overview

DeNova develops a naturally-derived, scalable, and sustainable microbial protein source using fermentation. Their product serves as an alternative to traditional plant and animal proteins with a lower carbon footprint and resource use. The company targets the food industry rather than healthcare or pharmaceuticals.

Industry: Non-Drug Biotech

Partnerships

Canada's Ocean Supercluster

Beyond the preview

Go deeper on DeNova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeNova.

Explore the full profile